Detalles de la búsqueda
1.
Prevalence of Enteric Infections in Patients on Immune Checkpoint Inhibitors and Impact on Management and Outcomes.
Oncologist
; 29(1): 36-46, 2024 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37721546
2.
Safety of Immunosuppression in A Prospective Cohort of Inflammatory Bowel Disease Patients with a HIstoRy of CancEr: SAPPHIRE Registry.
Clin Gastroenterol Hepatol
; 2024 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38768673
3.
Exocrine Pancreatic Insufficiency Induced by Immune Checkpoint Inhibitors.
Oncologist
; 28(12): 1085-1093, 2023 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37285223
4.
IL12/23 Blockade for Refractory Immune-Mediated Colitis: 2-Center Experience.
Am J Gastroenterol
; 118(9): 1679-1683, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37216614
5.
Efficacy of Infliximab Dose Escalation in Patients with Refractory Immunotherapy-Related Colitis: A Case Series.
Oncologist
; 27(4): e350-e352, 2022 04 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35380715
6.
Effect of Concomitant Therapy With Steroids and Tumor Necrosis Factor Antagonists for Induction of Remission in Patients With Crohn's Disease: A Systematic Review and Pooled Meta-analysis.
Clin Gastroenterol Hepatol
; 19(2): 238-245.e4, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32569749
7.
Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 17(12): 2497-2505.e1, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30625408
8.
Reply.
Clin Gastroenterol Hepatol
; 20(2): 469, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33839279
9.
Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.
Am J Gastroenterol
; 111(11): 1641-1648, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27575714
10.
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis.
Nat Commun
; 15(1): 2568, 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38531883
11.
Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation.
Cancer Immunol Res
; 12(3): 308-321, 2024 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38108398
12.
IL12/23 Blockade with Ustekinumab as a Treatment for Immune-Related Cutaneous Adverse Events.
Pharmaceuticals (Basel)
; 16(11)2023 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38004414
13.
Crohn's Disease Mortality and Ambient Air Pollution in New York City.
Inflamm Bowel Dis
; 2023 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37934758
14.
Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis.
J Immunother Cancer
; 11(6)2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37349130
15.
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis.
medRxiv
; 2023 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37292751
16.
Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers.
Nat Commun
; 14(1): 110, 2023 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36611031
17.
Response to Goyal and Katner.
Am J Gastroenterol
; 112(5): 806, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28469222
18.
Assessment of complication and functional outcome reporting in the minimally invasive prostatectomy literature from 2006 to the present.
BJU Int
; 109(1): 26-30; discussion 30, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21951696
19.
Facts and Hopes in Prediction, Diagnosis, and Treatment of Immune-Related Adverse Events.
Clin Cancer Res
; 28(7): 1250-1257, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34921018
20.
Contribution of the Skin-Gut Axis to Immune-Related Adverse Events with Multi-System Involvement.
Cancers (Basel)
; 14(12)2022 Jun 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35740660